Scientists at The Wistar Institute and ChristianaCare's Helen F. Graham Cancer Center discovered a cellular vulnerability in pancreatic cancer by identifying how defective mitochondria trigger inflammation that cancer cells depend
← News
Medicine Breakthroughs Medicine Breakthroughs Health
Blocking a cellular inflammation process could result in effective therapy for pancreatic cancer
The Wistar Institute & ChristianaCare'S Helen F. Graham Canc Research Location
Proceedings Of The National Academy Of Sciences Publication Venue
Pancreatic Cancer Cancer Type Studied
Mitochondrial-Triggered Inflammation Dependency Discovery Focus